Results: 428

Effects of crocin on brain oxidative damage and aversive memory in a 6-OHDA model of Parkinson's disease

Arq. neuropsiquiatr; 74 (9), 2016
ABSTRACT The purpose of the present study was to investigate the effect of crocin on brain oxidative damage and memory deficits in a 6-hydroxydopamine (6-OHDA) model of Parkinson’s disease. Male Wistar rats were subjected to unilateral injection of 6-OHDA (16 µg) into the medial forebrain bundle a...

Aspectos de comunicação oral em pacientes com doença de Parkinson submetidos à Estimulação Cerebral Profunda

CoDAS; 28 (4), 2016
RESUMO Introdução A Estimulação Cerebral Profunda tem sido considerada uma intervenção satisfatória para os sintomas motores cardinais da doença de Parkinson, porém ainda há poucas evidências sobre seu impacto na comunicação. Objetivo Esse trabalho teve como objetivo caracterizar os seguin...

Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s

Arq. neuropsiquiatr; 74 (8), 2016
ABSTRACT Most known by his literary ability, the words of the neurologist Oliver Sacks (1933-2015) also had an impact on scientific community about the role of levodopa on parkinsonisms. Different from the most authors and based on his experience described on the book “Awakenings”, he had a p...

Postural instability and falls are more frequent in Parkinson's disease patients with worse trunk mobility

Arq. neuropsiquiatr; 74 (7), 2016
ABSTRACT Postural instability and axial rigidity are frequent symptoms of the Parkinson’s disease (PD). Objective Correlate the occurrence of falls and the activity of rolling over in bed with performance on the Trunk Mobility Scale (TMS) in patients with PD, and determine whether this instrument...

Craniopuntura de Yamamoto na doença de Parkinson

Aprimorada ao longo de milênios a Medicina Tradicional Chinesa vem despertando o interesse da comunidade ocidental por ser uma terapia complementar eficaz para tratamento de diferentes patologias e sem efeitos colaterais importantes. Reconhecida pela Organização Mundial de Saúde e incorporada pelo Si...

Clozapina na psicose associada à doença de Parkinson

Contexto: Ao se delinear a revisão do Protocolo Clínico e Diretrizes Terapêuticas (PCDT) da doença de Parkinson (DP), observou-se a necessidade de garantir também o acesso ao tratamento com o antipsicótico clozapina, hoje disponível no SUS para o tratamento de esquizofrenia e transtorno esquizoafe...

Avaliação dos membros superiores na doença de Parkinson: implicações para a Reabilitação Física

Rev. bras. neurol; 52 (2), 2016
A doença de Parkinson é uma desordem neurológica com impacto negativo na motricidade e qualidade de vida dos pacientes. O comprometimento motor inclui dificuldades para a marcha, equilíbrio e atividades de vida diária. Contudo, pouca atenção é dada aos aspectos de avaliação e reabilitação fí...

Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report

Dement. neuropsychol; 10 (2), 2016
ABSTRACT Psychosis, impulse control disorders (e.g., pathological gambling and hypersexuality) and repetitive behaviors such as punding are known psychiatric complications of Parkinson's disease (PD). Impulsive, compulsive and repetitive behaviors are strongly associated with dopamine-replacement therapy...

The rs3857059 variant of the SNCA gene is associated with Parkinson's disease in Mexican Mestizos

Arq. neuropsiquiatr; 74 (6), 2016
ABSTRACT Among the candidate genes for Parkinson’s disease (PD), SNCA has replicated association in different populations. Besides other known mutations in the SNCA gene, the rs3857059 variant has also been linked to various neurodegenerative disorders. Therefore, the aim of the present study was t...

Presence or absence of cognitive complaints in Parkinson's disease: mood disorder or anosognosia?

Arq. neuropsiquiatr; 74 (6), 2016
ABSTRACT We intended to evaluate whether non-demented Parkinsons’s disease (PD) patients, with or without subjective cognitive complaint, demonstrate differences between them and in comparison to controls concerning cognitive performance and mood. We evaluated 77 subjects between 30 and 70 years, d...